Mitsubishi Power, Georgia Power, EPRI Complete World’s Largest Hydrogen Fuel Blending at Plant McDonough-Atkinson
The project demonstrates retrofitting of Mitsubishi Power’s fleet of advanced-class gas turbines to operate on…
Month: June 2022
Atrium Hospitality Promotes Rob Mangiarelli to President and Chief Operating Officer; Craig Mason Returns Full-time as President of Atrium Holding Company
ALPHARETTA, Ga.–(BUSINESS WIRE)–Atrium Hospitality, one of the nation’s largest hotel operators, announces the promotion of…
University of Phoenix announces transfer pathway agreement with Metropolitan Community College
Academic agreement supports pathway for students from community college to higher degrees at the University…
Harris Williams Advises Coastal Forest Resources Company on the Pending Sale of its Subsidiary, Coastal Plywood Company, to Boise Cascade Company
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
CDW Welcomes New Chief Marketing and Digital Officer and SVP of Strategy and Corporate Development
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–CDW (Nasdaq: CDW), today announced the addition of two new strategy and marketing…
Bermuda Launches First Digital Asset Industry Association of Fully Licensed and Regulated Companies at Consensus 2022
“NEXT” reflects Bermuda’s momentum in attracting institutional-grade digital asset companies seeking a credible regulatory jurisdiction…
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2022
MONTRÉAL, Québec, June 10, 2022 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”)…
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in…
Oncternal Therapeutics Presents Rationale and Plans for its Registrational Phase 3 Study Evaluating Zilovertamab in Combination with Ibrutinib at the EHA 2022 Congress
SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
ABVC BioPharma Announces Termination of Two Contracts
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
ORYZON at EHA-2022: Iadademstat 42-month ALICE Data Demonstrate Robust Efficacy in Combination with Azacitidine in AML
81% of evaluable patients achieved an objective response Deep responses: 64% are CR/CRi, of which…
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivo Future studies will…
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
Multiplex deletion of myeloid antigens CD33 and CLL-1 in human hematopoietic stem cells demonstrates potential…
Mindset Pharma Receives Notice of Allowance for Patent Application Covering Psilocin Derivatives for the Treatment of Central Nervous System Disorders
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Vincerx Pharma Presents Preclinical and Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Lymphoma at the European Hematology Association 2022 Congress
Preclinical data demonstrate VIP152 as the most selective CDK9 inhibitor compared with other CDK9 inhibitors,…
Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications
— Results, which were previously pre-printed in bioRxiv, show Gritstone’s second-generation self-amplifying mRNA (samRNA) vaccine…
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or…
GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions
First RSV vaccine candidate to show statistically significant and clinically meaningful efficacy in adults aged…
BridgeBio Pharma Affiliate Venthera Presents Preliminary Results from Clinical Trial of VT30 (BBP-681) for Venous, Lymphatic, and Venolymphatic Malformations
PALO ALTO, Calif., June 10, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio)…
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market
PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…